Over 100 Nintendo prototypes hit InsertBid in 2026, led by WATA-authenticated Hidden Treasures Collection development builds.

Prosecutors say automated plays of AI-generated songs fraudulently diverted royalties from human artists—to the tune of $8 ...

A deep dive into the iconic late-night block that shaped the tastes of a bleary-eyed, post-ironic generation of comedy fans.

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Logan Paul’s NFT has fallen more than 99% from its peak value. Celebrity NFT investments have broadly suffered steep losses. The NFT market has shrunk but not disappeared. When YouTuber Logan Paul ...

The crash of the NFT market led OpenSea to fire more than half of its staff. But the startup has reinvented itself into a place for buying and selling all tokens, including memecoins, and trading ...

Remember back in 2021 when everyone thought a cartoon monkey was the peak of human financial evolution? Well, we have come a long way since then. If you are reading this in 2026, you already know that ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...